Viewing Study NCT07064759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-28 @ 4:43 PM
Study NCT ID: NCT07064759
Status: RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor: 4D Molecular Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-Related Macular Degeneration (nAMD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age-related macular degeneration View
None AMD View
None Exudative AMD View
None Neovascular AMD View
None Exudative age-related macular degeneration View
None Neovascular age-related macular degeneration View
None Wet age-related macular degeneration View
None Wet macular degeneration View
None Wet AMD View
None WAMD View
None nAMD View
None Retinal gene therapy View
None Intravitreal gene therapy View
None Genetic Medicine View
None Ocular Gene Therapy View
None Gene Therapy View
None 4FRONT View
None 4FRONT-2 View